Mareike Roth
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
X-linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL.
Journal: EMBO molecular medicine
Published: May 14, 2021
A functional LSD1 coregulator screen reveals a novel transcriptional regulatory cascade connecting R-loop homeostasis with epigenetic regulation.
Journal: Nucleic acids research
Published: February 12, 2021
A kinase-independent role for CDK8 in BCR-ABL1+ leukemia.
Journal: Nature communications
Published: January 12, 2019
Author Correction: Necroptosis microenvironment directs lineage commitment in liver cancer.
Journal: Nature
Published: November 10, 2018
MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity.
Journal: Nature communications
Published: October 31, 2017
Necroptosis microenvironment directs lineage commitment in liver cancer.
Journal: Nature
Published: August 28, 2017
lncRNA requirements for mouse acute myeloid leukemia and normal differentiation.
Journal: eLife
Published: January 30, 2017
Molecular role of the PAX5-ETV6 oncoprotein in promoting B-cell acute lymphoblastic leukemia.
Journal: The EMBO journal
Published: August 14, 2016
MEK1 is required for the development of NRAS-driven leukemia.
Journal: Oncotarget
Published: July 20, 2016
Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies.
Journal: Blood
Published: March 07, 2015
Efficacy and mechanism of action of volasertib, a potent and selective inhibitor of Polo-like kinases, in preclinical models of acute myeloid leukemia.
Journal: The Journal of pharmacology and experimental therapeutics
Published: January 11, 2015
Transcriptional plasticity promotes primary and acquired resistance to BET inhibition.
Journal: Nature
Published: November 10, 2014
Last Updated: 09/26/2026